Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlaza Regulatory News (PLAZ)

Share Price Information for Plaza (PLAZ)

Share Price is delayed by 15 minutes
Get Live Data
14.50    0.00 (0.00%)
Bid:
7.00
Ask:
22.00
Spread: 15.00 (214.286%)
Market Cap: £994.06k
PLAZ Live PriceLast checked at - London Stock Exchange

Intraday Plaza Share Chart

RESTRUCTURING PROCESS UPDATE

26 Mar 2014 15:00

RNS Number : 2720D
Plaza Centers N.V.
26 March 2014
Β 

ο»Ώ

26 March 2014Β 

Β 

Plaza Centers N.V.

Β 

RESTRUCTURING PROCESS UPDATE

Β 

Further to the announcements made on 18 November 2013 regarding Plaza's debt restructuring process, the Company announces that it has agreed, based on comments and input provided by Hermetic and Reznik, Paz & Nevo, the trustees of the Israeli Series A and Series B Notes, respectively ("Trustees"), to make certain commercial amendments to the debt restructuring plan ("Amended Plan") that will be submitted to the competent court in the Netherlands in the near future and, immediately thereafter, published on the Company's website.

Β 

It is clarified that, although the Trustees support the Amended Plan, they are not in a position to bind the bondholders and actual approval of the Amended Plan and its terms remains subject to the creditors' voting, which is scheduled to be held on 26 June 2014, at 10:00 am CET, in the Herzberg Hall of the District Court of Amsterdam.

Β 

A general, high-level and non-exhaustive brief summary of the material agreed commercial terms are listed below:

Β· The Amended Plan shall be contingent upon the injection of a fresh €20 million into the Company ("Equity Contribution"), and will become effective only once the placing of the Equity Contribution shall have been occurred.

Β· The Company shall issue to holders of unsecured debt (i.e., outstanding debt under the Israeli Series A and B Notes and the Polish Notes) ("Unsecured Debt") 13.5% of the Company's shares (post the Equity Contribution) for no consideration. Such issuance of shares will be distributed among the holders of Unsecured Debt pro rata to the relative share of each relevant creditor in the Deferred Debt ("Deferred Debt Ratio").

Β· All principal payments due during the years 2013-2015 of any Unsecured Debt ("Deferred Debt") shall be deferred for three years from the date of approval of the Amended Plan by the court in the Netherlands ("Approval Date"). If within two years from the Approval Date the Company manages to repay 50% of the Deferred Debt, then the remaining principal payments of the Deferred Debt shall be deferred for an additional one year.

Β· Interest payments for the Unsecured Debt that were due during the suspension of payments period, will be added to the principal and paid together with it. Following the removal of the suspension of payments order ("Effective Date"), interest payments will be paid on their due dates.

Β· As of 1 January 2014, the annual interest rate of the Unsecured Debt shall be increased by 1.5%.

Β· Following the Effective Date, the Company shall pay to the holders of the Unsecured Debt an amount of €10.5 million on account of 2014 interest payments.

Β· The Company, its directors and officers and its controlling shareholder shall be fully released from claims.

Β· Following the Effective Date, the Company will have to assign 75% of the net proceeds received from the sale or refinancing of any of its assets to early repayment of the Unsecured Debt, to be allocated among the holders of Unsecured Debt in accordance with the Deferred Debt Ratio.

Β· The Company will be allowed to execute actual investments only if the Company's cash reserves contain an amount equal to general and administrative expenses and interest payments for the Unsecured Debt for a six-month period (for this purpose also receivables with a high probability of being collected in the subsequent six-month period will be taken in account for the required minimal cash reserve).

Β· The Amended Plan shall also include, inter alia: (i) certain limitations on distribution of dividends and incurring of new indebtedness; (ii) negative pledge on direct and indirect holdings of the Company on real estate assets; (iii) financial covenants and undertakings of the Company with respect to the sale and financing of certain projects and investment in new projects; and (iv) commitment to publish quarterly financial statements as long as the Unsecured Debt is outstanding.

Β 

Please note that the Amended Plan is yet to be finalised, therefore the above only provides a summary of the key material points without going into specific details. Full details of the Amended Plan, once submitted to the Dutch court, will be provided on the Company's website under Investor relations/ Debt restructuring. http://www.plazacenters.com/index.php?p=debt_restructuring.

Β 

Β 

Β 

For further details, please contact:

Β 

Plaza

Ran Shtarkman, President and CEO +36 1 462 7221

Roy Linden, CFO +36 1 462 7222

Β 

FTI Consulting

Stephanie Highett / Nina Legge +44 20 3727 1000

Β 

Notes to Editors

Β 

Plaza Centers N.V. (www.plazacenters.com) is a leading emerging markets developer of shopping and entertainment centres. It focuses on constructing new centres and, where there is significant redevelopment potential, redeveloping existing centres in both capital cities and important regional centres. The Company is dual listed on the Main Board of the London Stock Exchange and, as of 19 October 2007, on the Warsaw Stock Exchange (LSE:"PLAZ", WSE: "PLZ/PLAZACNTR"). Plaza Centers N.V. is an indirect subsidiary of Elbit Imaging Ltd. ("EI"), an Israeli public company whose shares are traded on both the Tel Aviv Stock Exchange in Israel and on the NASDAQ Global Market in the United States. It has been active in real estate development in emerging markets for over 17 years.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBSGDXSSDBGSL
Date   Source Headline
17th Aug 20107:00 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
11th Aug 20102:00 pmRNSNotice of Results
9th Aug 20102:00 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
29th Jul 20103:00 pmRNSBOND ISSUANCE PROGRAMME
28th Jun 20102:00 pmRNSInvestor Presentation
16th Jun 20107:30 amRNSAcquisition
15th Jun 20107:00 amRNSUpdate on US Joint Venture
27th May 20107:45 amRNSCompletion of Suwalki Plaza
25th May 20106:20 pmRNSResult of AGM
18th May 20108:00 amRNSInterim Management Statement
7th May 20108:00 amRNSNotice of AGM
30th Apr 20104:37 pmRNSAnnual Dutch Statutory Accounts and Annual Report
30th Apr 20102:35 pmRNSAnnual Dutch Statutory Accounts and Annual Report
22nd Apr 20107:36 amRNSAcquisition
24th Mar 20107:00 amRNSFinal Results
18th Feb 20102:45 pmRNSCredit rating
11th Feb 20107:00 amRNSSeries B Notes
9th Feb 20107:00 amRNSRe Joint Venture
26th Jan 20108:00 amRNSSeries B Notes
15th Jan 201010:03 amRNSCORRECTION: Reporting dates for 2010
15th Jan 20108:00 amRNSReporting dates for 2010
14th Jan 201010:18 amRNSBond rating
29th Dec 20097:30 amRNSDirector Declaration
18th Dec 20094:40 pmRNSSecond Price Monitoring Extn
18th Dec 20094:35 pmRNSPrice Monitoring Extension
27th Nov 20094:35 pmRNSPrice Monitoring Extension
19th Nov 20097:00 amRNSInterim Management Statement
6th Nov 20094:40 pmRNSSecond Price Monitoring Extn
6th Nov 20094:35 pmRNSPrice Monitoring Extension
27th Oct 20097:00 amRNSHolding(s) in Company
26th Oct 20097:00 amRNSSeries B Notes
12th Oct 20097:00 amRNSTransaction in Own Shares
7th Oct 200912:41 pmRNSHolding(s) in Company
15th Sep 20098:00 amRNSAcquisition
4th Sep 20094:41 pmRNSSecond Price Monitoring Extn
4th Sep 20094:35 pmRNSPrice Monitoring Extension
26th Aug 20098:00 amRNSHalf Yearly Report
25th Aug 20094:40 pmRNSSecond Price Monitoring Extn
25th Aug 20094:35 pmRNSPrice Monitoring Extension
12th Aug 200911:00 amRNSSeries B Notes
19th Jun 20098:00 amRNSDebt rating
26th May 20091:39 pmRNSResult of AGM
19th May 20099:00 amRNSInterim Management Statement
30th Apr 20098:00 amRNSAnnual Report and Dutch Statutory Accounts 2008
21st Apr 20094:40 pmRNSSecond Price Monitoring Extn
21st Apr 20094:35 pmRNSPrice Monitoring Extension
17th Apr 20094:35 pmRNSPrice Monitoring Extension
3rd Apr 20094:35 pmRNSPrice Monitoring Extension
30th Mar 20097:00 amRNSFinal Results
19th Mar 200911:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.